secwatch.observer — SEC 8-K summary
======================================

Issuer:     FATE THERAPEUTICS INC (FATE)
CIK:        0001434316
Form:       8-K
Filed at:   2023-04-19T23:59:59+00:00
Accession:  0000950170-23-013471
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 3.03, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Fate Therapeutics amends beneficial ownership limitation on Class A Convertible Preferred Stock to 14.99%
--------------------------------------------------------------------------------

- Filed Certificate of Amendment to Class A Convertible Preferred Stock Certificate of Designation on April 13, 2023.
- Beneficial Ownership Limitation set at 14.99% of outstanding common shares following conversion.
- Amendment modifies definition in Section 6(c) of the Certificate of Designation.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1434316/000095017023013471/0000950170-23-013471-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1434316/000095017023013471/fate-20230413.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-013471

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer